Nanopharmaceutical Drugs Market Size and Growth Factors Research and Projection 2027: Amgen Inc., AstraZeneca PLC, Gilead Sciences Inc., Novartis AG, F., Etc.
"The rising incidence of cancer is one of the significant factors influencing the market growth."
Vancouver, BC -- (SBWire) -- 12/22/2020 --Nanopharmaceutical Drugs Market
The global nanopharmaceutical drugs market size is forecasted to reach a value of USD 82.71 Billion by 2027 at a CAGR of 7.3% according to an analysis by Emergen Research. The nanopharmaceutical drugs market is observing high demand attributed to its increasing application in oncology, cardiovascular, immunology, neurology, and anti-biotic. Factors such as the rising incidence of cancer, increased investments, and technological advancements in disease diagnostic procedures will drive the market growth during the forecast period.
Key participants include Amgen Inc., AstraZeneca PLC, Gilead Sciences Inc., Novartis AG, F. Hoffmann-La Roche AG, AbbVie Inc., Johnson & Johnson, Pfizer Inc., Sanofi SA, and Merck & Co. Inc., among others.
Download Free Sample PDF Copy at https://www.emergenresearch.com/request-sample-form/378
Market Drivers
The microemulsion is likely to grow at the fastest rate of 8.3% of the nanopharmaceutical drugs market during the forecast period. Microemulsions have gained importance as these reduce drug toxicity and increase clinical potency. The application of nanopharmaceutical drugs in oncology accounted for the largest market share of over 36.0% in 2019. By distribution channel, hospital pharmacies accounted for the largest market share of over 57.0% of the nanopharmaceutical drugs market in 2019. The increased purchasing power of the people has led to an increase in the number of hospitals and pharmacies, globally, which has encouraged the growth of the nanopharmaceutical drugs market.
Type Outlook (Revenue, USD Billion; 2017-2027)
Liposomes
Polymeric Micelles
Microemulsion
Solid Lipid Nanoparticles
Nanoemulsion
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Neurology
Anti-Infective
Others
Distribution Channel Outlook (Revenue, USD Billion; 2017-2027)
Hospital Pharmacies
Retail Off-Line Pharmacies
Retail On-Line Pharmacies
Regional Analysis
The North American region held the highest market share of 47.2% of the nanopharmaceutical drugs market in the year 2019, owing to the highly developed healthcare services in the region. However, the Asia Pacific region is forecast to grow at the fastest CAGR during the forecast period, owing to the fast-developing healthcare sector and the expected growth in the number of super-speciality clinics in the region.
ORDER NOW (Customized Report Delivered as per Your Specific Requirement) @ https://www.emergenresearch.com/select-license/378
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Nanopharmaceutical Drugs Market Segmentation & Impact Analysis
4.1. Nanopharmaceutical Drugs Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rising incidence of cancer
4.2.2.2. Growing geriatric population
4.2.2.3. Increased investments in R&D activities
4.2.2.4. Technological advancements in disease diagnostic procedures
4.2.3. Market restraints analysis
4.2.3.1. Cost-prohibitive nanopharmaceutical drug discovery
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Nanopharmaceutical Drugs Market By Type Insights & Trends, Revenue (USD Million)
5.1. Type Dynamics & Market Share, 2019 & 2027
5.1.1. Liposomes
5.1.2. Polymeric Micelles
5.1.3. Microemulsion
5.1.4. Solid Lipid Nanoparticles
5.1.5. Nanoemulsion
5.1.6. Others
Chapter 6. Nanopharmaceutical Drugs Market By Application Insights & Trends Revenue (USD Million)
6.1. Application Dynamics & Market Share, 2019 & 2027
6.1.1. Oncology
6.1.2. Cardiovascular/Physiology
6.1.3. Anti-inflammatory/Immunology
6.1.4. Neurology
6.1.5. Anti-Infective
6.1.6. Others
6.1.7. Others
Chapter 7. Nanopharmaceutical Drugs Market By Distribution Channel Insights & Trends Revenue (USD Million)
7.1. Distribution Channel Dynamics & Market Share, 2019 & 2027
7.1.1. Hospital Pharmacies
7.1.2. Retail Off-Line Pharmacies
7.1.3. Retail On-Line Pharmacies
To be continued…!
Take a Look at our Related Reports:
Bioremediation Market Projected To Be Worth USD 334.70 Billion By 2027 Growing at a CAGR of 15.5% | Emergen Research
Cancer Imaging Systems Market To Reach USD 12.24 Billion by 2027 | Emergen Research
Embedded SIM (eSIM) Market Size To Be USD 3019.1 Million by 2027 | Emergen Research
AI-Enabled Medical Imaging Solutions Market Size To Be Worth USD 4,720.6 Million by 2027 | Emergen Research
Intelligent Drug Discovery Market Size To Be Worth USD 3,711.8 Million by 2027 | Emergen Research
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-nanopharmaceutical-drugs-market
Media Relations Contact
John Watson
1-604-757-9756
https://www.emergenresearch.com/industry-report/nanopharmaceutical-drugs-market
View this press release online at: http://rwire.com/1321371